Trevena
Trevena is a biopharmaceutical company developing medicines for central nervous system disorders. Its pipeline includes investigational TRV045, TRV250 and TRV734. Its FDA-approved acute-pain medicine OLINVYK (oliceridine) had U.S. commercial sales discontinued effective December31,2024. The company began operations in2007 and adopted the Trevena name in2008; it remains under restructuring with consulting officers.
Key facts
| CAGE Code | 5BXZ4 |
|---|---|
| Legal Name | Trevena, Inc. |
| Company Operating Status | Active |
| Full Address | 955 Chesterbrook Blvd, Suite 110, Chesterbrook, Pennsylvania 19087, US |
| Public/Private | Public |
| Stock Symbol | TRVN |
| Ticker Symbol | TRVN |
| Wellfound ID | trevena |
Contact details
Email and phone for Trevena are available to signed-in members of CliffBio.
Sign in to view